Prologue Medicines

Prologue is creating transformative medicines by systematically discovering and evaluating viral proteins and their unique features.

[Prologue Medicines @Prologue_Med]

It was energizing being surrounded by fellow #FlagshipFounded companies that are all taking #BiggerLeaps to shape the future of human and planetary health. At Prologue, this means uncovering the trove of possibilities hidden within the viral proteome.

#WeAreFlagship

[Prologue Medicines @Prologue_Med]

Get to know our recently announced Chief Scientific Officer Raj Chopra and his vision for innovation at Prologue in this @statnews interview: https://t.co/tiI97ElFEp #PeopleofPrologue #FlagshipFounded

[Prologue Medicines @Prologue_Med]

Next up in our #PeopleofPrologue series is Michael Askenase, a senior scientist II at Prologue. Read our full Q&A with Michael to learn more about his role and what makes Prologue a great place to work. #LifeAtPrologue #WeAreHiring #JoinUs

[Prologue Medicines @Prologue_Med]

We’re excited to welcome Dr. Raj Chopra as our Chief Scientific Officer. Learn more about Raj and how he will help us advance our mission to unlock the therapeutic potential of viral proteins and create transformative medicines: https://t.co/wHcFSpI4U5 #PeopleofPrologue

[Prologue Medicines @Prologue_Med]

Check out our president @theonie on the latest episode of the Careers in Discovery podcast. Hear what inspired her to pursue a career in science, and why curiosity is the most powerful tool a scientist can have: https://t.co/T0Ygco5txZ

#FlagshipFounded #PeopleofPrologue

[Prologue Medicines @Prologue_Med]

Prologue’s Co-Founder and CEO @afzelius_lovisa shared how we are unlocking the viral proteome to develop groundbreaking new therapies at the #FlagshipStudio during #JPM25. Watch the full CEO Chat: https://t.co/uhWBDEPJMO.

[Prologue Medicines @Prologue_Med]

In @FlagshipPioneer’s annual letter, Founder and CEO @NoubarAfeyan explores polyintelligence – the synthesis of human, machine, and nature's intelligence. Read more about how we’re using AI to unlock the viral proteome and develop groundbreaking therapies: https://t.co/2W4lq5ZqrW

[Prologue Medicines @Prologue_Med]

Meet Karan Tandon, associate scientist and our next feature in our #PeopleofPrologue series. We spoke with him about his background in protein science and automation, and what excites him about his work at Prologue. #LifeAtPrologue #WeAreHiring #JoinUs

[Prologue Medicines @Prologue_Med]

Our president @Theonie represented Prologue at @BosBusinessJournal’s Women Who Lead in Life Sciences Emerging Leaders panel where she shared insights on innovation and the importance of female leadership in biotech. Thanks to all who made the event a success! #FlagshipFounded

[Theonie @theonie]

Ahead of this year’s @BosBusinessJournal’s Women Who Lead in Life Sciences event, I got to talk with @hannah_reports about my path to exploring the boundaries of biology at @FlagshipPioneer, @Prologue_Med, and @alltrna.
https://t.co/rvxGr6gJkr

[Prologue Medicines @Prologue_Med]

To kick off our #PeopleofPrologue series, we caught up with Shruti Pratapa, a senior scientist II. We spoke with her about why she decided to pursue a career in research, and what she wishes people understood about viruses. #LifeAtPrologue #WeAreHiring #JoinUs

[Prologue Medicines @Prologue_Med]

Over the weekend, we joined our CEO @afzelius_lovisa and president @theonie at a celebratory picnic for our team and families. We had a great time commemorating our recent launch and looking to the future.

[Lovisa Afzelius @afzelius_lovisa]

Last weekend, @AprioriBio, @MetaphoreBio, Prologue Medicines, FL101, and FL104, along with families and friends, gathered for our inaugural summer picnic. It was great to get to know those important to you and enjoying quality time together outside of work. #FlagshipFounded

[Prologue Medicines @Prologue_Med]

Exciting news from @FlagshipPioneer with the raise of $3.6 billion to power more innovations in human health. We are proud to be a #FlagshipFounded company as we unlock the therapeutic potential of the viral proteome for transformational patient outcomes.

[Flagship Pioneering @FlagshipPioneer]

Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO @NoubarAfeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. ​Read the full press release: https://t.co/uQt9hWJ6r0

[Prologue Medicines @Prologue_Med]

At Prologue, we believe that groundbreaking discoveries can only be made by a team that enjoys working together, strives to push boundaries, & has a little fun along the way. Learn about us: https://t.co/MbZxaRj6XT
#FlagshipFounded

[Prologue Medicines @Prologue_Med]

What can we do with our DELVE™ Platform?

By combining computation & high-throughput biology we aim to reveal the therapeutic potential of the viral proteome and program the next generation of medicines at speed and scale.

Learn more: https://t.co/AoWTMnUMJm #FlagshipFounded

[Prologue Medicines @Prologue_Med]

We sat down with @GENbio to share how advances in AI & machine learning are enabling us to systematically mine the viral proteome for the first time. Read the article to learn more about Prologue, including our novel DELVE™ platform. https://t.co/MKpnTLT8nr #Flagshipfounded

[Prologue Medicines @Prologue_Med]

With our DELVE™ Platform, we're the first company to systematically mine the viral proteome. This enables us to create medicines for a wide range of diseases: https://t.co/AoWTMnUMJm #FlagshipFounded

[Prologue Medicines @Prologue_Med]

Prologue's @afzelius_lovisa & @theonie caught up with @endpts' @RLCscienceboss to share how we're systematically mining the viral proteome to predict the function of viral proteins, how they may alter human biology, & where they may be useful in treating disease. Read below⬇️

[Ryan Cross the Science Boss @RLCscienceboss]

“People have really focused on the prevention of viruses. And what we’re really doing is kind of flipping that on its head.”

@FlagshipPioneer startup Prologue Medicines is searching the viral proteome for new drugs. Read more in my story for @endpts:

https://t.co/YA7uWusXGk

[Prologue Medicines @Prologue_Med]

We're excited to announce our launch as Prologue Medicines.

As a @FlagshipPioneer company, we're unlocking the therapeutic potential of the viral proteome for the creation of powerful new medicines. Learn more: https://t.co/OwBgNa3bFJ
#FlagshipFounded